CAMP Q3 2022 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73M-7.8% YoY

Gross Profit

$29M39.8% margin

Operating Income

-$5M-7.3% margin

Net Income

-$7M-10.3% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+12.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$371M

Total Liabilities

$349M

Stockholders' Equity

$22M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$79M	-7.8%
Gross Profit	$29M	$33M	-13.1%
Operating Income	-$5M	-$998,000	-435.0%
Net Income	-$7M	-$5M	-38.1%

Revenue Segments

Product

$46M63%

Application Subscriptions And Other Services

$27M37%

Geographic Segments

UNITED STATES

$46M63%

E M E A

$12M17%

Latin America

$8M11%

Asia Pacific

$6M8%

All Other

$534,0001%